Researchers have revealed that two classes of compounds, already available in the pharmaceutical industry, may work against the Zika virus infections, according to an article on Nature Medicine. The ...

A new non-addictive class of compounds developed by researchers at Purdue’s College of Pharmacy could lead to the treatment of chronic pain conditions, such as back pain and arthritis, in the absence ...

Researchers analyzing routine urine samples have stumbled onto a previously unrecognized group of industrial chemicals that ...

Researchers at Washington University School of Medicine in St. Louis have developed a new class of compounds that can improve multiple aspects of metabolic syndrome. The compounds act as modulators of ...

Tuberculosis has been infecting humans for several millennia, making it one of the most horribly successful diseases in history. Today, it is still a major killer, responsible for some 1.5 million ...

A new drug derived from magnolia trees appears to be able to uncouple two important functions of thrombin in blood clot formation and may offer a way to better control the potentially dangerous ...

The preclinical study by the Drug Discovery and Development (D3) unit of the Italian Institute of Technology and the University of California, Irvine, showed that URB937, a potent, second-generation ...

A $500,000 drug development grant from the National Multiple Sclerosis Society (NMSS) was awarded to a partnership between a multiple sclerosis research team at the Icahn School of Medicine at Mount ...

Drug utilization management tools can be employed to ensure that medicines are prescribed cost-effectively, but they can also be implemented in ways that reduce adherence and harm patient health. We ...